BBDA BeBevCo?What are your thoughts on BBDA BeBevCo company? Here is what I know about them. They are the exact opposite of 5 hour energy drinks and appear to have a niche in the 5 hour liquid relaxation category. They recently were granted the rights to sell in all 78 stores in South Carolina. The big […]
Articles
- Most Relevant
- Most Recent
This thread is designed to allow Irregulars to discuss, share and provide input for calender catalyst events, primarily but not limited to equities contained on the Green Tab of the KSS Da Man! spreadsheet that is maintained by Hi Pockets. The calender currently can be updated only by Benny, Lawrence, Dr. KSS and myself. The […]
MAKE YOUR PORTFOLIO GREAT AGAIN ! This thread is a continuation of several threads posted previously by the author on gold and silver and hard asset investments. I am still a believer in hard assets. I also believe we are entering a period of inflation with continued dollar devaluation, higher interest rates, and a sluggish […]
This tread is created for serious cannabis investors to share K.A.S.H. by providing ideas, diligence, links, equities, etc. with like-minded individuals.
Streetsifter strikes again — he sent in this solution for an email that just started circulating, and he sent it in before I had even gotten around to reading the email. He even wrote it up nicely, so most of what follows is just a minor edit of his words (I agree he’s clearly got […]
I follow SG by subscribing to the emailed comment notifications and use them to collect KSS’ comments for maintaining the Love KSS spreadsheet (more about that later, see the current KSS thread for its URL). I go to a thread online only (usually) when I need to clarify something about a KSS statement. Since […]
Hi folks — this is a submission from a reader that I haven’t yet looked at, so you can follow up for yourselves. Don’t want to delay it while I try to find time, so have at it: The email ad in question is for the Venture Insider, and you may have seen this one […]
Hi Doc, There is a teaser which talks about 3 hot companies working on pain relieving which can provide huge gains apparently. It mentions about an Arizona and Vancouver-based companies .. http://www.angelnexus.com/o/web/68345/ Google search for delta-9 gave the following companies which are doing phase3 clinical trials .. InMed Pharmaceuticals http://investorshub.advfn.com/InMed-Pharmaceuticals-Inc-IMLFF-28415/ http://www.marketwatch.com/story/inmed-pharma-proprietary-platform-growing-pipeline-low-valuation-2014-10-29 GW Pharma and Insys […]
Wondering if you are going to look into the advert? I am not sure of the protocol but i have been following your methods for a year or more and love to eugooglize. So i came up with my own guesses for the pitch for the Personal Finance newsletter i received today. I am a […]
Cytodyn (CYDY) is a stock that was discussed in depth here around 4 years ago. The company makes a monoclonal antibody called leronlimab (formerly known as PRO 140) which is a CCR5 inhibitor for treating HIV. The BLA has been submitted for it and the FDA has granted it fast track designation and a decision […]
Sometimes literary gimmicks backfire. In May 2015, we premiered “Cisco, Chang & Charlie” (sans Oxford comma) as a James Joycean brooding on the letter C, third letter of the alphabet, in three iterations. At the time, three stocks whose names begin with C were vying for attention and prompting questions from readers. The original plan […]
[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]
We will no longer be publishing the commentary of Dr. KSS, who wrote about biotech stocks for the Irregulars for several years. Late last week, he decided to move on and resign from his work here. I imagine he will likely start his own publication of some sort in the future — all I know […]
[Ed. Note: Here is our second installment from Dr. KSS, formerly known as “karmaswimswami” in Gumshoe discussion threads. Dr. KSS has agreed to our trading and disclosure restrictions, and he’s not offering you personal investment or medical advice. As with all of our columnists, we don’t assign topics or opinions and do just a bit of light […]
[Ed. note: Today we have another article from Jim Skelton, the Blind Squirrel, who writes to share what he learned about investing in his many years in the trenches as a financial advisor. He has agreed to our trading restrictions, the opinions he expresses are his own, and we haven’t reviewed, approved or screened his […]
Noblecon13 Live Blog — notes from Dr. KSS from the Noble Capital Markets Small Cap & Emerging Growth Investor Conference January 30-31.
Travis- I so much appreciate and enjoy you and the exceptional irregular-shoes here. I have several thoughts/ideas I’d like share: Have you ever considered: 1. A ”Beyond the decimal” (sub penny) and/or pre- and after-market discussion area(s)? 2. An investor tools link area i.e. finvis, barchart, bloomberg, otcmarkets, zacks etc, not only for links but […]
We’d added some more services for our readers to review on the site. If you have any experience with any of these, we’d love to get your opinion: FastCash.biz: http://www.stockgumshoe.com/reviews/fastcash-biz/ Fast Money Alert: http://www.stockgumshoe.com/reviews/fast-money-alert/ Ace Trades: http://www.stockgumshoe.com/reviews/ace-trades/ Thank you!
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He chooses his own topics, and his words and opinions are his own.] Careful analysis of Ebola sequences in infected Africans confirms this: the entire present Ebola outbreak emerged as a consequence of one boy in Meliandoua, in eastern Guinea, eating a […]
A brief factual video about H2O as an introduction: https://www.youtube.com/watch?v=VIaw5mCjHPI This discussion thread is dedicated to to the many facets of H2O and how we may conserve, share, transport, desalinate etc. and profit from this essential life giving resource that is now approaching a global crisis in many areas of our planet. Best2ALL!-Ben
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
The Value Investing Congress is always an interesting place to hear about ideas and strategies from some of the better money managers and analysts around, but I’m finding it particularly valuable this year … when the market is going through crazy gyrations and moving up and down on macro news like European debt or unemployment […]
Before I start out with today’s “Idea of the Month” article I should note that I’ve had a lot of folks asking about the new “teaser” language coming from Dan Ferris for his Extreme Value newsletter — so let me quickly jump on that before I share this month’s stock idea, since it’s a stock […]
Tom Jacobs runs one of the “premium” newsletter services at the Motley Fool — they call it Special Ops, and I’ve written about it before … but that happened to be for the Irregulars in the Friday File, so many of you might have missed it. Special Ops says it looks for, as you might […]
Happy Friday! Here’s the pitch from Yiannis Mostrous that got me interested today: “… the population of children aged zero to 14 has decreased steadily year after year… “… yet sales of children’s products have exploded—from USD 11 billion in 2005 to USD 30 billion in 2009. “This apparent disconnect is the direct result of […]
“When this controversial law takes effect on October 1, 2011… folks who act now could get ‘hedge fund rich’” That’s how Zachary Scheidt is launching his new service, called Hedge Fund Strategist from Taipan, a publisher in the Baltimore Agora-plex (Taipan is currently in the process of renaming itself “Insiders Strategy Group,” just to keep […]
Happy Friday! Here’s the pitch from Yiannis Mostrous that got me interested today: “… the population of children aged zero to 14 has decreased steadily year after year… “… yet sales of children’s products have exploded—from USD 11 billion in 2005 to USD 30 billion in 2009. “This apparent disconnect is the direct result of […]
I suppose I should expect this by now — whenever Frank Curzio and the gang put out a teaser for Phase 1 Investor, which is the big-money newsletter from Stansberry & Associates ($5,000/year, though almost always “on sale” at $3,000 when they’re running promos), my inbox gushes like Spindletop. Didn’t matter if it was a […]
Jeff Opdyke, who writes the Global Growth Strategist newsletter ($895 per year, thanks very much) for the Sovereign Society, is teasing us about a small-cap way to get in on the “Cybornetic web revolution” … and lots of Gumshoe readers have been asking for an unveiling of this mystery that costs a bit less than […]
Time once again, dear children, for a tale from the Middle Kingdom. Once upon a time, there was a nation so vast and populous that investors got dollar signs in their eyes just gazing upon the smoggy mega-cities that grew like weeds in that distant land. And lo, it was told that it was just […]
Yiannis Mostrous teased us well over a year ago about the stock that he thought was “the next McDonald’s” … and readers are telling me that he’s sending out a very similar ad campaign right now, so I thought I’d take a look. At the time, Mostrous was looking for subscribers to his Silk Road […]
OK, so the folks at Cabot make it quite a habit to say “double your money in 2011 guaranteed” — that’s the promise they make when promoting each of their picks from the Cabot Stock of the Month newsletter, which is sold as a monthly “best of” selection from the stable of Cabot newsletters. Cabot’s […]
A couple notes for you before I get into the investment idea that I want to feature this month: First, thanks to the new folks who have joined this week — quite a few folks came on board in response to the teaser barrage for Sandstorm Gold, which is still being very actively teased by […]
As with many past promotions from the folks at Cabot’s Stock of the Month newsletter, they’re comparing their new pick to First Solar, and guaranteeing that the shares will double in a matter of months (or your money back … and yes, that’s the subscription money, not the money you might have lost on the […]
This time around I thought I’d get into some more detail for you on a stock I’ve written about before, and which I own personally — but I think it’s underappreciated given its potential for inflation protection and dividend growth. April’s Idea of the Month is shares of Retail Opportunity Investments Corp (ROIC). That ROIC […]
This time around I thought I’d get into some more detail for you on a stock I’ve written about before, and which I own personally — but I think it’s underappreciated given its potential for inflation protection and dividend growth. April’s Idea of the Month is shares of Retail Opportunity Investments Corp (ROIC). That ROIC […]
Today’s teaser ad comes in from Nathan Slaughter, who’s trying to entice us to subscribe to his Scarcity & Real Wealth newsletter, a new offering from the StreetAuthority folks that’s focused, as you can probably guess, on investing in mining, energy and commodities. And though the ad has been running for about two weeks as […]
Mike Williams, who edits the True Income newsletter from Stansberry & Associates, has been trying to get new subscribers by promising to reveal the secrets of the “32% clause” that can pay you a huge annual income stream. So what on earth is he talking about? Here’s how the ad begins: “Introducing: A completely legal […]
Untold millions of readers (OK, not millions — in the tradition of the folks we write about every day, we’ll use quotes that enable us to make stuff up … so, untold “millions”) have been asking us about the “long-lost” treasure maps that are chatted up in Sean Broderick’s latest teaser for his Red-Hot Global […]
Robert Hsu has been running this teaser ad for his Asia Edge newsletter for a week or two now, and I’ve gotten enough questions that it seems there’s some demand for the Gumshoe version (ie, the free version) of the answer. It seems unlikely, by the way, that this tease about the “Facebook of China” […]